Stronger Sell Today ABUS ranks #4208 as SELL CANDIDATE. Weaker Sell
Today ABUS ranks #4208 as SELL CANDIDATE.

ABUS stock Arbutus Biopharma Corporation

ABUS stock
Arbutus Biopharma Corporation

22 January 2019
Change -4.07%
Chart period: 2018-10-23 - 2019-01-22
VOLUME
Sell
TREND
Sell

MV LONG
Sell

MV SHORT
Sell

PIVOT
Sell

MACD
Buy
Request Prediction
Predict

Arbutus Biopharma Corporation Stock Analysis

Technical stock analysis for 22 January 2019

Sell candidate since 2019-01-07 Loss -15.71%
Shorts n/a
Cash n/a
Loans n/a
Beta 2.11
ROA -34.25

Arbutus Biopharma Corporation fell by -4.07% in the last day from $3.69 to $3.54 and has now fallen 3 days in a row. The price has fallen in 7 of the last 10 days and is down by -15.71% for this period. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -25 870 shares and in total 134 906 shares bought and sold for approximately $477 567.00.

Close price at the end of the last trading day (Tuesday, 22nd Jan 2019) of the ABUS stock was $3.54. This is 4.07% less than the trading day before Friday, 18th Jan 2019.

During day the stock fluctuated 8.29% from a day low at $3.50 to a day high of $3.79.

30 day high of the ABUS stock price was $4.35 and low was $3.20.
90 day high was $5.66 and low was $3.20.
52 week high for the Arbutus Biopharma Corporation - $12.60 and low - $3.20.

Trend

Arbutus Biopharma Corporation lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -18.82% during the next 3 months and, with 90% probability hold a price between $2.50 and $3.70 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

There are few to none technical positive signals at the moment. Arbutus Biopharma Corporation holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $3.70 and $4.07. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Thursday January 17, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 44 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Arbutus Biopharma Corporation finds support from accumulated volume at $3.51.

Support: $3.51 Price: $3.54 Resistance: $3.77

Risk

This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.29 between high and low, or 8.29%. For the last week the stock has had a daily average volatility of 8.64%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High

Evaluation

Arbutus Biopharma Corporation holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our recommendation for this stock since last evaluation from a Strong Sell Candidate to a Sell Candidate.

Stronger Sell Today ABUS ranks #4208 as SELL CANDIDATE. Weaker Sell
Today ABUS ranks #4208 as SELL CANDIDATE.